MedPath

European Non-invasive Trisomy Evaluation (EU-NITE Study): Evaluation of a targeted analysis of cell free fetal DNA in maternal blood for prenatal diagnosis of fetal trisomies.

Completed
Conditions
chromosomal aberration
trisomy
10083624
Registration Number
NL-OMON36065
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
630
Inclusion Criteria

Singleton pregnancy with gestational age between 9 and 23 weeks, informed consent.

Exclusion Criteria

Invasive procedure performed prior to taking the blood sample, history or active significant malignancy in the mother requiring major surgery or systemic chemotherapy, language restriction with failure to understand the study information.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>detection rate of trisomies with Tandem SNPs</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath